Evaluation of the Efficacy and Safety of DW1903 in Patients with Gastritis: A Randomized, Double-Blind, Noninferiority, Multicenter, Phase 3 study.
Jie-Hyun KimHwoon Yong JungIn Kyung YooSeon-Young ParkJae-Gyu KimJae Kyu SungJin Seok JangGab Jin CheonKyoung Oh KimTae Oh KimSoo Teik LeeKwang Bum ChoHoon Jai ChunJong-Jae ParkMoo In ParkJae Young JangSeong Woo JeonJin Woong ChoDae Hwan KangGwang Ha KimJae J KimSang Gyun KimNa Young KimYong Chan LeeSu Jin HongHyun Soo KimSora LeeSang Woo LeePublished in: Gut and liver (2023)
DW1903 of a low-dose PPI was not inferior to DW1903R1 of H2RA. Thus, lowdose PPI can be a novel option for treating gastritis (ClinicalTrials.gov Identifier: NCT05163756).